How Does Novartis AG (NVS) Rank In Terms Of Valuation Ratios?

The stock of Novartis AG (NYSE:NVS) increased by $0.43 on Tuesday to finish at $81.49, up 0.53 percent. The last five days have seen an average of 2,481,540 shares of common stock traded. 10 times new highs were reached in the current year, with a fall of -$5.98. The average number of shares traded over the last 20 days was 2,169,030, while the average volume over the last 50 days totaled 2,484,054.

NVS stock dropped -8.08% since last month. On 06/14/22, the company’s shares reached a one-month low of $80.15. The stock touched a high of $95.17 on 04/11/22, after rallying from a low of $79.09 in 52 weeks. The price of NVS stock has declined by -6.84% or -$5.98 this year, reaching a new high 10 times. Still, the stock price is down -14.37% from the 52-week high.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Valuation Metrics

Novartis AG (NVS) has a trailing price-to-earnings (P/E) ratio of 7.59. Beta for the stock is 0.56. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 3.63, the price-to-book (PB) ratio of 2.95, and the price-to-cash flow ratio of 33.81.

Company paid $1.1750 per share in dividends, a decrease of -65.22% from $3.378380 last year. A $2.203380 dividend decrease was reported on Thursday February 3 2022.

Financial Health

For the three months ended March 30, Novartis AG’s quick ratio was 1.00, while its current ratio was 1.20, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending March 30 is 0.40, and the total debt to equity ratio is 0.51. As far as profitability goes, gross margin for the trailing twelve months is 71.00% percent. Novartis AG’s operating margin stood at 22.90% for the same period. Based on annual data, it had gross profit of $37.01 billion and revenue of $52.88 billion.

Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. NVS’s return on assets (ROA) during the last 12 months has been 19.30%. There was a 9.70% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 40.30%.

Earnings Surprise

According to Novartis AG’s quarterly financial report for the quarter that ended March 30, it had $278.0 million in cash and short-term investments. A lower net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $52.88 billion, while revenues rose by 5.63% to $0.0. It was predicted that Novartis AG’s quarterly earnings would be $1.46, but it ended up being $1.46. EBITDA was $2.85 billion for the quarter. At the end of Novartis AG’s most recent quarter ended March 30, its liabilities totaled 63.51 billion, while its total debt was $31.34 billion.

Technical Picture

Here’s a quick look at Novartis AG’s (NVS) price momentum from a technical perspective. As of 21 June, the RSI 9-day stood at 27.45%, suggesting the stock is oversold, with a 19.72% historical volatility rate.

The stochastic %K and %D were 9.79% and 10.49% respectively, while the average true range (ATR) was 1.56. Based on the 14-day stochastic reading of 12.95%, the RSI (14) reading is 31.24%. On the 9-day MACD Oscillator, the stock is at -1.60, and the 14-day reading is at -3.80.

Analyst Ratings

Novartis AG (NYSE: NVS) was downgraded by Wolfe Research to a a Peer perform rating in its latest research report. The stock was previously rated as a an Outperform.


Please enter your comment!
Please enter your name here

Hot Topics

Related Articles




Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam